The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block it.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

New research suggests that carbonated water may offer a small boost to weight loss by speeding up digestion, improving ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from the National Institutes of Health to support the Neuro-Oncology Translational Research ...

A 3D model accurately mimicking the blood-brain barrier (BBB) in a laboratory environment has been successfully developed by ...

Tinnitus Awareness Week is marked by the first full week of February. WashU Medicine’s Dr. Jay Piccirillo joined First Alert ...

A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.

Unique approach improves efficiency of conventional bone graft scanning process, reaching more patientsALACHUA, Fla., February 3, 2025 – Evergen ...

Health First Cardiothoracic Surgeon Seiichi Noda has vivid memories of his childhood, spending time with his father at the hospital where he worked as a neurosurgeon in Japan. Those visits had a ...

Everyone has probably dealt with at least a little physical pain in their life.But fortunately, the number of peop ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.